These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 24608191)

  • 1. Histologic subtypes of breast cancer following radiotherapy for Hodgkin lymphoma.
    Horst KC; Hancock SL; Ognibene G; Chen C; Advani RH; Rosenberg SA; Donaldson SS; Hoppe RT
    Ann Oncol; 2014 Apr; 25(4):848-851. PubMed ID: 24608191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic features of breast cancers diagnosed in women treated with prior radiation therapy for Hodgkin lymphoma: Results from a population-based cohort.
    Wong SM; Ajjamada L; Weiss AC; Prakash I; Skamene S; Boileau JF; Pollak MN; Basik M
    Cancer; 2022 Apr; 128(7):1365-1372. PubMed ID: 34919263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Locoregional treatment for breast carcinoma after Hodgkin's lymphoma: the breast conservation option.
    Haberer S; Belin L; Le Scodan R; Kirova YM; Savignoni A; Stevens D; Moisson P; Decaudin D; Pierga JY; Reyal F; Campana F; Fourquet A; Bollet MA
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e145-52. PubMed ID: 21605948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer in patients irradiated for Hodgkin's disease: a clinical and pathologic analysis of 45 events in 37 patients.
    Yahalom J; Petrek JA; Biddinger PW; Kessler S; Dershaw DD; McCormick B; Osborne MP; Kinne DA; Rosen PP
    J Clin Oncol; 1992 Nov; 10(11):1674-81. PubMed ID: 1403050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics and outcomes of breast cancer in women with and without a history of radiation for Hodgkin's lymphoma: a multi-institutional, matched cohort study.
    Elkin EB; Klem ML; Gonzales AM; Ishill NM; Hodgson D; Ng AK; Marks LB; Weidhaas J; Freedman GM; Miller RC; Constine LS; Myrehaug S; Yahalom J
    J Clin Oncol; 2011 Jun; 29(18):2466-73. PubMed ID: 21576642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk, characteristics, and prognosis of breast cancer after Hodgkin's lymphoma.
    Veit-Rubin N; Rapiti E; Usel M; Benhamou S; Vinh-Hung V; Vlastos G; Bouchardy C
    Oncologist; 2012; 17(6):783-91. PubMed ID: 22588325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast Imaging in Women Previously Irradiated for Hodgkin Lymphoma.
    Horst KC; Fero KE; Hancock SL; Advani RH; Ikeda DM; Daniel B; Rosenberg SA; Donaldson SS; Hoppe RT
    Am J Clin Oncol; 2016 Apr; 39(2):114-9. PubMed ID: 24390271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of breast cancer subtypes on the response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer patients.
    Stamatovic L; Susnjar S; Gavrilovic D; Minic I; Ursulovic T; Dzodic R
    J BUON; 2018; 23(5):1273-1280. PubMed ID: 30570847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abundant tumor infiltrating lymphocytes after primary systemic chemotherapy predicts poor prognosis in estrogen receptor-positive/HER2-negative breast cancers.
    Watanabe T; Hida AI; Inoue N; Imamura M; Fujimoto Y; Akazawa K; Hirota S; Miyoshi Y
    Breast Cancer Res Treat; 2018 Feb; 168(1):135-145. PubMed ID: 29168063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic susceptibility to radiation-induced breast cancer after Hodgkin lymphoma.
    Opstal-van Winden AWJ; de Haan HG; Hauptmann M; Schmidt MK; Broeks A; Russell NS; Janus CPM; Krol ADG; van der Baan FH; De Bruin ML; van Eggermond AM; Dennis J; Anton-Culver H; Haiman CA; Sawyer EJ; Cox A; Devilee P; Hooning MJ; Peto J; Couch FJ; Pharoah P; Orr N; Easton DF; Aleman BMP; Strong LC; Bhatia S; Cooke R; Robison LL; Swerdlow AJ; van Leeuwen FE
    Blood; 2019 Mar; 133(10):1130-1139. PubMed ID: 30573632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of subsequent in situ and invasive breast cancer in human epidermal growth factor receptor 2-positive ductal carcinoma in situ.
    Curigliano G; Disalvatore D; Esposito A; Pruneri G; Lazzeroni M; Guerrieri-Gonzaga A; Luini A; Orecchia R; Goldhirsch A; Rotmensz N; Bonanni B; Viale G
    Ann Oncol; 2015 Apr; 26(4):682-687. PubMed ID: 25600567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic role of HER2 expression in ductal breast carcinoma in situ (DCIS); a population-based cohort study.
    Borgquist S; Zhou W; Jirström K; Amini RM; Sollie T; Sørlie T; Blomqvist C; Butt S; Wärnberg F
    BMC Cancer; 2015 Jun; 15():468. PubMed ID: 26062614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening mammography for young women treated with supradiaphragmatic radiation for Hodgkin's lymphoma.
    Lee L; Pintilie M; Hodgson DC; Goss PE; Crump M
    Ann Oncol; 2008 Jan; 19(1):62-7. PubMed ID: 17878177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bilateral breast cancer after Hodgkin disease. Clinical and pathological characteristics and therapeutic possibilities: an analysis of 13 cases].
    Cutuli B; de La Rochefordière A; Dhermain F; Borel C; Graic Y; de Lafontan B; Dilhyudy JM; Mignotte H; Tessier E; Tortochaux J; N'Guyen T; Bey P; Le Mevel-Le Pourhier A; Arriagada R
    Cancer Radiother; 1997; 1(4):300-6. PubMed ID: 9435820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast Cancer Risk After Radiation Therapy for Hodgkin Lymphoma: Influence of Gonadal Hormone Exposure.
    Krul IM; Opstal-van Winden AWJ; Aleman BMP; Janus CPM; van Eggermond AM; De Bruin ML; Hauptmann M; Krol ADG; Schaapveld M; Broeks A; Kooijman KR; Fase S; Lybeert ML; Zijlstra JM; van der Maazen RWM; Kesminiene A; Diallo I; de Vathaire F; Russell NS; van Leeuwen FE
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):843-853. PubMed ID: 28888722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the HER2 status in BRCA-mutated breast cancer: a single institutional series and systematic review with pooled analysis.
    Tomasello G; Gambini D; Petrelli F; Azzollini J; Arcanà C; Ghidini M; Peissel B; Manoukian S; Garrone O
    ESMO Open; 2022 Aug; 7(4):100531. PubMed ID: 35810556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of breast cancer subtype on survival after palliative radiation for osseous metastases.
    Abdelhakiem MK; Johnstone C; Bergom C; Currey A; Robbins JR
    Cancer Med; 2020 Dec; 9(23):8979-8988. PubMed ID: 33146466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxorubicin Exposure and Breast Cancer Risk in Survivors of Adolescent and Adult Hodgkin Lymphoma.
    Neppelenbroek SIM; Geurts YM; Aleman BMP; Lugtenburg PJ; Rademakers SE; de Weijer RJ; Schippers MGA; Ta BDP; Plattel WJ; Zijlstra JM; van der Maazen RWM; Nijziel MR; Ong F; Schimmel EC; Posthuma EFM; Kersten MJ; Böhmer LH; Muller K; Koene HR; Te Boome LCJ; Bilgin YM; de Jongh E; Janus CPM; van Leeuwen FE; Schaapveld M
    J Clin Oncol; 2024 Jun; 42(16):1903-1913. PubMed ID: 38359378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer and cardiovascular outcomes after breast cancer in survivors of Hodgkin lymphoma.
    Krul IM; Boekel NB; Kramer I; Janus CPM; Krol ADG; Nijziel MR; Zijlstra JM; van der Maazen RWM; Roesink JM; Jacobse JN; Schaapveld M; Schmidt MK; Opstal-van Winden AWJ; Sonke GS; Russell NS; Aleman BMP; van Leeuwen FE
    Cancer; 2022 Dec; 128(24):4285-4295. PubMed ID: 36281718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of breast cancer after Hodgkin's lymphoma and paediatric cancer.
    Terenziani M; Massimino M; Magazzù D; Gandola L; Capri G; Carcangiu ML; Catania S; Di Russo A; Gennaro M; Meazza C; Podda M; Schiavello E; Valagussa P
    Eur J Cancer; 2015 Sep; 51(13):1667-74. PubMed ID: 26092639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.